Skip to main content
. 2021 Jun 26;9(4):e00786. doi: 10.1002/prp2.786

FIGURE 5.

FIGURE 5

Effects of eribulin on stathmin expression in breast cancer cell lines. MCF7 and MDA‐MB‐231 cells were treated for 3 or 6 days with various concentrations of eribulin (1, 3, or 10 nM). A: Cell lysates were subjected to immunoblot analysis to detect stathmin. GAPDH served as a loading control. B: Cell viability was evaluated in a WST‐8 assay